Physician profile
Amanda B Eckhardt
NPI 1689196750
$4,146.63
in general payments reported to CMS, 2019-2025
32 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what 81% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $517 · 2022: $482 · 2023: $1,046 · 2024: $1,046 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,148.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $645.45 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $579.31 | 2021-2025 | Lifevest |
| Ethicon US, LLC | $503.28 | 2023-2025 | Echelon; Endopath, Vistaseal, Surgicel Nu-Knit |
| Abiomed | $372.24 | 2023 | Impella |
| Merck Sharp & Dohme LLC | $318.23 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Edwards Lifesciences Corporation | $217.50 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Davol INC. | $197.33 | 2024-2025 | Progel Applicator Spray Tips |
| Inari Medical, INC. | $152.28 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Silk Road Medical, INC. | $149.27 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Convatec INC. | $134.61 | 2024 | |
| Zimmer Biomet Holdings, INC. | $131.47 | 2021-2022 | |
| Saphena Medical, INC. | $98.34 | 2023 | Venapax |
| Regeneron Healthcare Solutions, INC. | $91.58 | 2025 | Dupixent |
| Genentech, INC. | $78.27 | 2023 | Alecensa |
| Kerecis Limited | $50.98 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $44.78 | 2021-2023 | Prevena, Prevena Restor Arthroform |
| Baxter Healthcare | $33.60 | 2023 | Preveleak |
| Sanara Medtech INC. | $31.77 | 2021 | |
| Boston Scientific Corporation | $28.83 | 2021 | |
| Trevena, INC. | $28.29 | 2021-2022 | |
| Stryker Corporation | $28.23 | 2021 | |
| Eisai INC. | $27.42 | 2025 | |
| Medtronic, INC. | $25.35 | 2023 | Corevalve Evolut R |
| Cerus Corporation | $24.57 | 2023 | Intercept Blood System For Platelets |
| Smith+Nephew, INC. | $24.05 | 2025 | Renasys |
| Abbott Laboratories | $23.41 | 2023 | Epic |
| E.R. Squibb & Sons, L.L.C. | $21.84 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.24 | 2021 | |
| Janssen Biotech, INC. | $19.38 | 2025 | Erleada, Akeega, Balversa |
| Biomerieux INC | $17.07 | 2023 | Nephrocheck Liquid Control Kit |
| Crossroads Orthopedics, LLC | $13.52 | 2023 | |
| On Target Laboratories, INC | $13.14 | 2025 | Cytalux |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Eckhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.